Lori E Dodd (Lori Dodd)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Replacement Therapy

Coronavirus Disease

Top Venues

Science translational medicine

Statistics in medicine

Annals of internal medicine

Clinical trials (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Amin Yarahmadi, Lori E Dodd, Thomas F Jaki, Peter W Horby, Nigel Stallard
Group sequential designs for clinical trials when the maximum sample size is uncertain. Statistics in medicine (2024)
Michael A Proschan, Dean A Follmann, Lori E Dodd
How to Quantify and Interpret Treatment Effects in Comparative Clinical Studies of COVID-19. Annals of internal medicine 174 (5) (2021)
Yingda L Xie, Veronique R de Jager, Ray Y Chen, Lori E Dodd, Praveen Paripati, Laura E Via, Dean A Follmann, Jing Wang, Keith Lumbard, Saher Lahouar, Stephanus T Malherbe, Jenna Andrews, Xiang Yu, Lisa C Goldfeder, Ying Cai, Kriti Arora, Andre G Loxton, Naadira Vanker, Michael Duvenhage, Jill Winter, Taeksun Song, Gerhard Walzl, Andreas H Diacon, Clifton Earl Barry
Fourteen-day PET/CT imaging to monitor drug combination activity in treated individuals with tuberculosis. Science translational medicine 13 (579) (2021)
Lori E Dodd, Dean A Follmann, Michael A Proschan, Jing Wang, Denis Malvy, Johan van Griensven, Iza Ciglenecki, Peter W Horby, Rashid Ansumana, Jia-Fu Jiang, Richard T Davey, Henry Clifford Lane, Aurelie Gouel-Cheron
A meta-analysis of clinical studies conducted during the West Africa Ebola virus disease outbreak confirms the need for randomized control groups. Science translational medicine 11 (520) (2020)
Lori E Dodd, Dean A Follmann, Jing Wang, Franz Koenig, Lisa L Korn, Christian Schoergenhofer, Michael Proschan, Sally Hunsberger, Tyler Bonnett, Mat Makowski, Drifa Belhadi, Yeming Wang, Bin Cao, France Mentre, Thomas F Jaki
Endpoints for randomized controlled clinical trials for COVID-19 treatments. Clinical trials (London, England) 17 (5) (2020)